After repeated failures in previous research, a new study suggests hydroxychloroquine can improve survival odds for some coronavirus patients. He also blamed the FDA's warning for depriving doctors at Henry Ford and elsewhere from doing gold standard clinical trial study of hydroxychloroquine for coronavirus patients. They gave coronavirus patients hydroxychloroquine earlier on in the course of their illnesses, and only if they were not at high risk for heart problems. Data also suggested that it might stem inflammation from an out-of-control immune response that often becomes the ultimate cause of death for severely ill coronavirus patients. 'This looks very promising,' he said of the Henry Ford study.

Source: Daily Mail July 03, 2020 15:42 UTC